rediff News http://www.rediff.com/tags/biotechnology+regulatory+authority+of+india+b India's largest news and entertainment service online.. en-us Sat, 23 Jul 16 19:52:48 +0000 Sat, 23 Jul 16 19:52:48 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[Educating India, in a B-Grade American style]]> http://www.rediff.com/money/column/guest-educating-india-in-a-b-grade-american-style/20100318.htm Sun, 24 Jul 2016 01:22:48 +0530 <![CDATA[Finance Minister P Chidambaram's speech]]> http://www.rediff.com/money/report/bud26/20070228.htm Sun, 24 Jul 2016 01:22:48 +0530 <![CDATA[Chidambaram's Budget speech]]> http://www.rediff.com/money/report/speech/20060228.htm Sun, 24 Jul 2016 01:22:48 +0530 <![CDATA[Biotech sector eyes $4,500 mn by '10]]> http://www.rediff.com/money/report/bio/20051201.htm Sun, 24 Jul 2016 01:22:48 +0530 <![CDATA[First Indian Pharmacovigilance Day conference to be held in Mumbai]]> http://www.financialexpress.com/pharma/latest-updates/first-indian-pharmacovigilance-day-conference-to-be-held-in-mumbai/325916/ Sun, 24 Jul 2016 01:22:48 +0530 <![CDATA[Seattle Genetics and Takeda Announce Publication of Final Data from ADCETRIS® Brentuximab Vedotin Monotherapy Pivotal Phase 2 Clinical Trial in Relap...]]> http://news.indiaonline.in/press-releases/Seattle-Genetics-and-Takeda-Announce-Publication-of-Final-Data-from-ADCETRIS-Brentuximab-Vedotin-Monotherapy-Pivotal-Phase-Clinical-Trial-in-Relapsed-or-Refractory-Classical-Hodgkin-Lymphoma-in-Blood-36245 Sun, 24 Jul 2016 01:22:48 +0530 <![CDATA[Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology..]]> http://in.advfn.com/p.php?pid=nmona&article=71651602 Sun, 24 Jul 2016 01:22:48 +0530